“showed a trend”

Although gender showed a trend toward increased asthma risk in males (OR, 2.04; 95% CI, 0.95–4.36; p =0.067), this finding was not statistically significant.

The increase of pyruvate, reporting on intra-mitochondrial 3-mercaptopyruvate hydrolysis by 3MPST, was small (3.6%) but showed a trend for significance (from 3582 ± 5934 to 3713 ± 623 μg/L; W: P = .067; T: P = .052) whereas sulfates reporting on H 2 S oxidation in the generation of ATP non-significantly increased by 5.5%.

While hypertension showed a trend toward increased stroke risk, it did not reach statistical significance in this analysis (p = 0.067).

Comparisons between the two groups Since ANOVA and post hoc testing showed a trend for significance between patients with treatment-resistant depression and those with acute depression in some scales (paranoia, P = 0.0670; mania, P = 0.1074), we used Student's t-test to detect small differences between the two groups.

Experiment 2: Adult morphology In adulthood, PA female pancreatic sections, compared to controls, showed a trend ( P = 0.067) towards reduced fraction of small islets, ranging from 100 to 1100 μm 2 in size (data not shown) and decreased islet counts ( P = 0.068; control 8.25 (±0.75); PA 6.11 (±0.74))/μm 2 ×10 −6 ) (data not shown).

Additionally, the effect of gender as a factor showed a trend on CAS Affect, with women experiencing more pain then men ( F (1, 100) = 3.433; p = 0.067, partial η 2 = 0.033), and there was no significant interaction between these variables ( F (1, 100) = 0.170; p = 0.681, partial η 2 = 0.002).

In the Telenoid condition, cortisol levels showed a trend toward reduction, t (11) = 2.57, p = 0.067, suggesting a potential decrease post-session.

In MDD, females showed a trend increase in KMO mRNA compared to female controls ( p = 0.067) (Fig. 1C ).

Results Circulating C19MC microRNAs were up-regulated (miR-517-5p, p = 0.005; miR-518b, p = 0.013; miR-520h, p = 0.021) or showed a trend toward up-regulation in patients destined to develop preeclampsia (miR-520a-5p, p = 0.067; miR-525-5p, p = 0.073).

Subgroup analyses showed a trend for greater upper-body strength improvements for males on creatine compared with females on creatine ( p = 0.067, Q = 3.366).

In summary, the F ‐test for this linear regression was not significant but showed a trend ( F [1,20] = 3.76, p = .067).

This is consistent with the fact that bladder V70 showed the largest effect size (R2 =0.115) among all DVH parameters and showed a trend toward statistical significance (p=0.067).

Regarding the gray matter, MOG 35-55 immunization showed a trend to increase the GFAP immunostaining levels in IL6-DIO-Het compared with those with BSA immunization ( p = 0.067), being this difference statistically significant when we counted the number of GFAP+ cells.

The relative expression of Gbp4 was significantly reduced (** P < 0.01), while Irgb6 and Gbp5 showed a trend toward reduction ( P = 0.067), but no change was observed in Ly6a or Zbp1 expression in infected IFN-γR −/− mice compared to wild-type (WT) controls ( Fig. 2A ).

13.2 ± 4.3, t = 3.17, p = 0.002), while in Florence these differences showed a trend p (17.3 ± 5.3 vs. 15.3 ± 4.5, t = 1.86, p = 0.067), which is shown in Table 3 .

Recipients of auto-HSCT with COVID-19 were older and showed a trend towards a higher incidence of arterial hypertension (28% vs 10%, p=0.067) without statistical differences in other comorbidities; active disease requiring treatment at COVID-19 diagnosis was more frequent in auto-HSCT recipients (65% vs. 21%, p<0.001).

Though CCNB1 showed a trend, no significance was observed ( p = 0.067; p = 0.065).

The intention (OR 1.9; 95% CI 0.7–5.3; p = 0.192) scores showed a trend for higher chances of reaching the VO 2peak reference values, whereas perceived behavior control (OR 0.4; 95% CI 0.2–1.0; p = 0.067) and subjective norms (OR 0.8; 95% CI 0.4–1.5; p = 0.491) scores showed the opposite tendency.

Female FEP cases showed a trend toward higher C4A expression levels compared to male cases (Mann–Whitney test p = 0.067), whereas the above association was not present in healthy participants (Mann–Whitney test p = 0.749).

However, when comparing baseline to Simeox ® treatment, although the treatment effect was not significant for the R 5 Hz, the treatment effect showed a trend with a p -value = 0.067.

sc IFN β‐1a‐ versus placebo‐treated patients Patients treated with sc IFN β‐1a had a lower mean (±SD) number of new/enlarging lesions ( n = 273; 6.9 ± 10) compared with placebo‐treated patients ( n = 134; 10.9 ± 16, p < 0.01), while the lesion volume increase of new/enlarging lesions showed a trend towards reduction in treated patients (0.47 ± 0.99 vs. 0.88 ± 1.48 cm 3 , p = 0.067), after adjusting for age, sex, center, and conversion.

At 1 year, functional class remained similar between the groups ( p = 0.095) ( Figure 6 B), whereas at the last follow-up, patients with VP ≥ 85% showed a trend toward worse NYHA distribution compared with those with VP < 85% ( p = 0.067 for 2 × 2; p = 0.145 for 4 × 2) ( Figure 6 C).

The non-SC subtype was an independent prognostic factor for both worse PFS (adjusted-HR = 1.62; p = 0.016) and OS (adjusted-HR = 1.64; p = 0.015), whereas a Ki-67 index of ≥55% (significantly enriched in the SC subgroup; Table 1 ) was an independent prognostic factor for worse PFS (adjusted-HR = 1.80; p = 0.028) and showed a trend towards worse OS (adjusted-HR = 1.63; p = 0.067).

Significant main effect differences between grads and non-grads were found for CK, Cl, DHEA-S and TCO2, while NE serum levels showed a trend by graduate status (p = 0.067) ( Table 2 ).

A binomial test showed a trend toward female predominance ( P = 0.067), but this was not statistically significant.